ABBOTT LABORATORIES — Director's Dealing 2019

Apr 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2019-03-31

Reporting Person: Contreras Jaime (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-31	Common shares without par value	A	935	—	Acquired	3530	Indirect
2019-03-31	Common shares without par value	F	385	$79.94	Disposed	3145	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	34706	Direct
Common shares without par value	22	Indirect
Common shares without par value	153319	Indirect
Common shares without par value	12081	Indirect

Footnotes

F1: Excludes 68,740 shares previously directly owned which were transferred to the Jaime Contreras Marvan 2006 Living Trust on March 26, 2019.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of April 1, 2019.

F3: Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.

F4: This grant represents a restricted stock unit award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting on each anniversary of the grant date. The award includes the right to have stock withheld for tax purposes.

F5: The reporting person disclaims beneficial ownership of all securities held by his spouse.

F6: Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.